Monoclonal antibody immunoconjugates for cancer treatment
- 30 June 1989
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 1 (5) , 891-894
- https://doi.org/10.1016/0952-7915(89)90066-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Trichokirin, a ribosome‐inactivating protein from the seeds of Trichosanthes kirilowii MaximowiczEuropean Journal of Biochemistry, 1988
- Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1JNCI Journal of the National Cancer Institute, 1988
- Site‐specific linkage of methotrexate to monoclonal antibodies using an intermediate carrierInternational Journal of Cancer, 1988
- Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxinJAMA, 1988
- Reshaping human antibodies for therapyNature, 1988
- Uptake of native and deglycosylated ricin A-chain immunotoxins by mouse liver parenchymal and non-parenchymal cells in vitro and in vivoBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- Biodistribution of methotrexate-monoclonal antibody conjugates and complexes: experimental and clinical studiesCancer Treatment Reviews, 1987
- Monoclonal antibody drug conjugates for site-directed cancer chemotherapy: preclinical pharmacology and toxicology studiesCancer Treatment Reviews, 1987
- Human monoclonal antibodies and monoclonal antibody multispecificityBritish Journal of Cancer, 1987
- Redesigning Nature's Poisons to Create Anti-Tumor ReagentsScience, 1987